Drug recall · October 19, 2016
TAZORAC recall
Why: Failed Content Uniformity Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
TAZORAC (tazarotene) Gel 0.05%, Rx only, packaged in 15 x 3.5 g professional sample containers, Manufactured by: Allergan Inc., Irvine, CA 92512. UPC: 300238335159.
- Lots / codes
Lot # 85037; Exp 05/17 Lot # 82583; Exp 10/16
- Quantity
- 17,112 tubes
- Company
- Allergan Sales, LLC, Waco, TX
- Distribution
- Nationwide
- Initiated
- June 30, 2016 · Voluntary: Firm initiated
- Classified
- October 13, 2016
- Reported
- October 19, 2016
- Ended
- December 6, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tazarotene
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.